表紙SALE
市場調查報告書
商品編碼
1025672

細胞治療藥製造的市場預測、競爭趨勢、成長機會 (∼2026年):各治療方法、細胞區分、運用規模、採購、用途、終端用戶、地區

Global Cell Therapy Manufacturing Market, By Therapy, By Source of Cell, By Scale of Operation, By Source, By Application, By End User, By Region, Competition Forecast & Opportunities, 2026

出版日期: | 出版商: TechSci Research | 英文 119 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

  • 全貌
  • 簡介
  • 目錄
簡介

全球細胞治療藥製造的市場在預測期間內預計以大幅度的年複合成長率成長。

全球生物醫藥品產業急速成長,促進該市場的成長。還有先進威脅治療方法開發,幾個生命的疾病變化也帶動今後5年的市場成長。再加上新型冠狀病毒感染疾病 (COVID-19)的全球性流行在市場在成長上也發揮了重要作用。

本報告提供全球細胞治療藥製造的市場調查,市場定義和概要,COVID-19以及其他的市場影響因素分析,客戶的迴響分析,專利趨勢,臨床試驗趨勢,市場規模的變化、預測,各治療方法、細胞區分、運用規模、採購、用途、終端用戶的明細,各地區、主要國家的詳細分析,競爭環境,市場佔有率,主要企業簡介等彙整資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 摘要整理

第4章 COVID-19的影響

第5章 客戶的迴響

第6章 全球市場預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各治療法
      • T細胞療法
      • 樹突狀細胞療法
      • 癌細胞療法
      • 幹細胞療法
    • 細胞各種類
      • 自體
      • 同種異體
    • 各運用規模
      • 前臨床
      • 臨床
      • 商業
    • 各採購
      • 公司內部
      • 受託製造
    • 各用途
      • 腫瘤
      • 心血管疾病
      • 整形外科疾病
      • 其他
    • 各終端用戶
      • 醫藥、生物科技企業
      • 學術、調查機關
      • 其他
    • 各企業
    • 各地區
  • 產品市場地圖

第7章 北美市場分析、預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各治療法
    • 各細胞種類
    • 各運用規模
    • 各採購
    • 各用途
    • 各終端用戶
    • 各國

第8章 歐洲市場分析、預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各治療法
    • 各細胞種類
    • 各運用規模
    • 各採購
    • 各用途
    • 各終端用戶
    • 各國

第9章 亞太地區市場分析、預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各治療法
    • 各細胞種類
    • 各運用規模
    • 各採購
    • 各用途
    • 各終端用戶
    • 各國

第10章 南美市場分析、預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各治療法
    • 各細胞種類
    • 各運用規模
    • 各採購
    • 各用途
    • 各終端用戶
    • 各國

第11章 中東、非洲市場分析、預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各治療法
    • 各細胞種類
    • 各運用規模
    • 各採購
    • 各用途
    • 各終端用戶
    • 各國

第12章 市場動態

  • 促進因素
  • 課題

第13章 市場趨勢

第14章 專利分析

第15章 臨床試驗

第16章 競爭情形

  • 競爭預測
  • 企業簡介
    • KBI Biopharma, Inc.
    • Waisman Biomanufacturing
    • Cell and Gene Therapy Catapult
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA
    • Catalent Inc.
    • Lonza Group
    • Oxford Biomedica Plc
    • Fujifilm Cellular Dynamics, Inc.
    • Wuxi Apptec
    • Charles River Laboratories International, Inc.
    • The Discovery Labs LLC
    • ABL, Inc.
    • BioCentriq
    • Commercializing Living Therapies

第17章 策略性建議

第16章 關於本公司&免責聲明

目錄
Product Code: 7729

Global cell therapy manufacturing market is projected to grow in the forecast period, 2022-2026 with an impressive CAGR. The market growth can be attributed to rapid growth of biopharmaceutical industries, all over the globe. The development of the advancing therapies and transforming paradigm of several life threatening diseases is driving the growth of the global cell therapy manufacturing market in the upcoming five years. The ongoing COVID-19 pandemic has played a significant role in growth of the global cell therapy manufacturing market. Healthcare industry was involved with the extensive research and technological advancements that leads to the advanced medicine and treatment facilities for the patients. The urgent need for effective therapies as well as vaccine against the infection supported the exponential growth in the market in the past two years. The market is expected to sustain similar growth in future five years on the same factor. Although the research is consistently growing, the expertise in the sector is limited and the lack of specialized infrastructure to produce cell therapies and various product development may cause a mild restraint on the future growth of the market.

The global cell therapy manufacturing market is segmented on the basis of therapy, source of cell, scale of operation, source, application, end user, competitional landscape, and regional distribution. Based on basis of therapy, the market is further bifurcated into T-cell therapies, dendritic cell therapies, tumor cell therapies, and stem cell therapies. Stem cell therapy is anticipated to hold the largest shares of the market and dominate the segment in the next five years on the account of rising research and development in the area. Stem cells therapy are utilized for the cures of various chronic diseases and the consistent efforts to provide the best available treatment to the patients. Additionally, growing number of ongoing clinical trials and increased stem cell therapy products in the market is aiding the growth of the global cell therapy manufacturing market in the upcoming five years. Rising FDA approvals, and dedicated biopharma companies for the consistent evolution of the cell therapies are also substantiating the growth of the global cell therapy manufacturing market in the next five years.

Holding the major shares of the global cell therapy manufacturing market are KBI Biopharma, Inc., Waisman Biomanufacturing, Cell and Gene Therapy Catapult, Thermo Fisher Scientific, Inc., Merck KGaA, Catalent Inc., Lonza Group, Oxford Biomedica Plc, Fujifilm Cellular Dynamics, Inc., Wuxi Apptec, Charles River Laboratories International, Inc., The Discovery Labs LLC, ABL, Inc., BioCentriq, Commercializing Living Therapies, among others. Market players are actively involved in the research and technological development in the medical applications of the cell therapy and related developments. The advanced technology has made it possible for the healthcare industry to provide excellent healthcare services through cell therapy manufacturing. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: 2016 - 2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022 - 2026

Objective of the Study:

  • To analyze the historical growth of the market size of global cell therapy manufacturing market from 2016 to 2019.
  • To estimate and forecast the market size of global cell therapy manufacturing market from 2020 to 2026 and growth rate until 2026.
  • To classify and forecast global cell therapy manufacturing market based on therapy, source of cell, scale of operation, source, application, end user, competitional landscape, and regional distribution.
  • To identify dominant region or segment in the global cell therapy manufacturing market.
  • To identify drivers and challenges for global cell therapy manufacturing market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global cell therapy manufacturing market.
  • To identify and analyze the profile of leading players operating in global cell therapy manufacturing market.
  • To identify key sustainable strategies adopted by market players in global cell therapy manufacturing market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and distributors across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of global cell therapy manufacturing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Manufacturers, end users, and other stakeholders
  • Distributors and suppliers of products and other stakeholders
  • Organizations, forums, and alliances related to cell therapy manufacturing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global cell therapy manufacturing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Cell Therapy Manufacturing Market, By Therapy:

T-Cell Therapies

Dendritic Cell Therapies

Tumor Cell Therapies

Stem Cell Therapies

  • Global Cell Therapy Manufacturing Market, By Source of Cell:

Autologous

Allogenic

  • Global Cell Therapy Manufacturing Market, By Scale of Operation:

Preclinical

Clinical

Commercial

  • Global Cell Therapy Manufacturing Market, By Source:

In-House

Contract Manufacturing

  • Global Cell Therapy Manufacturing Market, By Application:

Oncology

Cardiovascular Diseases

Orthopedic Diseases

Others

  • Global Cell Therapy Manufacturing Market, By End User:

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Others

  • Global Cell Therapy Manufacturing Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global cell therapy manufacturing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Cell Therapy Manufacturing Market

4. Voice of Customer

  • 4.1. Popularly used cells for Cell Therapy Manufacturing
  • 4.2. Commonly Used Cell Therapies
  • 4.3. Brand Awareness

5. Executive Summary

6. Global Cell Therapy Manufacturing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Therapy (T-Cell Therapies, Dendritic Cell Therapies, Tumor Cell Therapies, Stem Cell Therapies)
    • 6.2.2. By Source of Cell (Autologous v/s Allogenic)
    • 6.2.3. By Scale of Operation (Preclinical, Clinical, Commercial)
    • 6.2.4. By Source (In-House v/s Contract Manufacturing)
    • 6.2.5. By Application (Oncology, Cardiovascular Diseases, Orthopedic Diseases, Others)
    • 6.2.6. By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)
    • 6.2.7. By Company (2020)
    • 6.2.8. By Region
  • 6.3. Product Market Map

7. North America Cell Therapy Manufacturing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Therapy
    • 7.2.2. By Source of Cell
    • 7.2.3. By Scale of Operation
    • 7.2.4. By Source
    • 7.2.5. By Application
    • 7.2.6. By End User
    • 7.2.7. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Cell Therapy Manufacturing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Therapy
        • 7.3.1.2.2. By Source of Cell
        • 7.3.1.2.3. By Scale of Operation
        • 7.3.1.2.4. By Source
        • 7.3.1.2.5. By Application
        • 7.3.1.2.6. By End User
    • 7.3.2. Mexico Cell Therapy Manufacturing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Therapy
        • 7.3.2.2.2. By Source of Cell
        • 7.3.2.2.3. By Scale of Operation
        • 7.3.2.2.4. By Source
        • 7.3.2.2.5. By Application
        • 7.3.2.2.6. By End User
    • 7.3.3. Canada Cell Therapy Manufacturing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Therapy
        • 7.3.3.2.2. By Source of Cell
        • 7.3.3.2.3. By Scale of Operation
        • 7.3.3.2.4. By Source
        • 7.3.3.2.5. By Application
        • 7.3.3.2.6. By End User

8. Europe Cell Therapy Manufacturing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Therapy
    • 8.2.2. By Source of Cell
    • 8.2.3. By Scale of Operation
    • 8.2.4. By Source
    • 8.2.5. By Application
    • 8.2.6. By End User
    • 8.2.7. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Cell Therapy Manufacturing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Therapy
        • 8.3.1.2.2. By Source of Cell
        • 8.3.1.2.3. By Scale of Operation
        • 8.3.1.2.4. By Source
        • 8.3.1.2.5. By Application
        • 8.3.1.2.6. By End User
    • 8.3.2. Germany Cell Therapy Manufacturing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Therapy
        • 8.3.2.2.2. By Source of Cell
        • 8.3.2.2.3. By Scale of Operation
        • 8.3.2.2.4. By Source
        • 8.3.2.2.5. By Application
        • 8.3.2.2.6. By End User
    • 8.3.3. United Kingdom Cell Therapy Manufacturing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Therapy
        • 8.3.3.2.2. By Source of Cell
        • 8.3.3.2.3. By Scale of Operation
        • 8.3.3.2.4. By Source
        • 8.3.3.2.5. By Application
        • 8.3.3.2.6. By End User
    • 8.3.4. Italy Cell Therapy Manufacturing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Therapy
        • 8.3.4.2.2. By Source of Cell
        • 8.3.4.2.3. By Scale of Operation
        • 8.3.4.2.4. By Source
        • 8.3.4.2.5. By Application
        • 8.3.4.2.6. By End User
    • 8.3.5. Spain Cell Therapy Manufacturing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Therapy
        • 8.3.5.2.2. By Source of Cell
        • 8.3.5.2.3. By Scale of Operation
        • 8.3.5.2.4. By Source
        • 8.3.5.2.5. By Application
        • 8.3.5.2.6. By End User

9. Asia-Pacific Cell Therapy Manufacturing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Therapy
    • 9.2.2. By Source of Cell
    • 9.2.3. By Scale of Operation
    • 9.2.4. By Source
    • 9.2.5. By Application
    • 9.2.6. By End User
    • 9.2.7. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Cell Therapy Manufacturing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Therapy
        • 9.3.1.2.2. By Source of Cell
        • 9.3.1.2.3. By Scale of Operation
        • 9.3.1.2.4. By Source
        • 9.3.1.2.5. By Application
        • 9.3.1.2.6. By End User
    • 9.3.2. India Cell Therapy Manufacturing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Therapy
        • 9.3.2.2.2. By Source of Cell
        • 9.3.2.2.3. By Scale of Operation
        • 9.3.2.2.4. By Source
        • 9.3.2.2.5. By Application
        • 9.3.2.2.6. By End User
    • 9.3.3. South Korea Cell Therapy Manufacturing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Therapy
        • 9.3.3.2.2. By Source of Cell
        • 9.3.3.2.3. By Scale of Operation
        • 9.3.3.2.4. By Source
        • 9.3.3.2.5. By Application
        • 9.3.3.2.6. By End User
    • 9.3.4. Japan Cell Therapy Manufacturing Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Therapy
        • 9.3.4.2.2. By Source of Cell
        • 9.3.4.2.3. By Scale of Operation
        • 9.3.4.2.4. By Source
        • 9.3.4.2.5. By Application
        • 9.3.4.2.6. By End User
    • 9.3.5. Australia Cell Therapy Manufacturing Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Therapy
        • 9.3.5.2.2. By Source of Cell
        • 9.3.5.2.3. By Scale of Operation
        • 9.3.5.2.4. By Source
        • 9.3.5.2.5. By Application
        • 9.3.5.2.6. By End User

10. South America Cell Therapy Manufacturing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Therapy
    • 10.2.2. By Source of Cell
    • 10.2.3. By Scale of Operation
    • 10.2.4. By Source
    • 10.2.5. By Application
    • 10.2.6. By End User
    • 10.2.7. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cell Therapy Manufacturing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Therapy
        • 10.3.1.2.2. By Source of Cell
        • 10.3.1.2.3. By Scale of Operation
        • 10.3.1.2.4. By Source
        • 10.3.1.2.5. By Application
        • 10.3.1.2.6. By End User
    • 10.3.2. Argentina Cell Therapy Manufacturing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Therapy
        • 10.3.2.2.2. By Source of Cell
        • 10.3.2.2.3. By Scale of Operation
        • 10.3.2.2.4. By Source
        • 10.3.2.2.5. By Application
        • 10.3.2.2.6. By End User
    • 10.3.3. Colombia Cell Therapy Manufacturing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Therapy
        • 10.3.3.2.2. By Source of Cell
        • 10.3.3.2.3. By Scale of Operation
        • 10.3.3.2.4. By Source
        • 10.3.3.2.5. By Application
        • 10.3.3.2.6. By End User

11. Middle East and Africa Cell Therapy Manufacturing Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Therapy
    • 11.2.2. By Source of Cell
    • 11.2.3. By Scale of Operation
    • 11.2.4. By Source
    • 11.2.5. By Application
    • 11.2.6. By End User
    • 11.2.7. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Cell Therapy Manufacturing Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Therapy
        • 11.3.1.2.2. By Source of Cell
        • 11.3.1.2.3. By Scale of Operation
        • 11.3.1.2.4. By Source
        • 11.3.1.2.5. By Application
        • 11.3.1.2.6. By End User
    • 11.3.2. Saudi Arabia Cell Therapy Manufacturing Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Therapy
        • 11.3.2.2.2. By Source of Cell
        • 11.3.2.2.3. By Scale of Operation
        • 11.3.2.2.4. By Source
        • 11.3.2.2.5. By Application
        • 11.3.2.2.6. By End User
    • 11.3.3. UAE Cell Therapy Manufacturing Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Therapy
        • 11.3.3.2.2. By Source of Cell
        • 11.3.3.2.3. By Scale of Operation
        • 11.3.3.2.4. By Source
        • 11.3.3.2.5. By Application
        • 11.3.3.2.6. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Patent Analysis

15. Clinical Trials

16. Competitive Landscape

  • 16.1. Competition Outlook
  • 16.2. Company Profiles (SWOT Analysis of Top 5 Players Profiled)
    • 16.2.1. KBI Biopharma, Inc.
    • 16.2.2. Waisman Biomanufacturing
    • 16.2.3. Cell and Gene Therapy Catapult
    • 16.2.4. Thermo Fisher Scientific, Inc.
    • 16.2.5. Merck KGaA
    • 16.2.6. Catalent Inc.
    • 16.2.7. Lonza Group
    • 16.2.8. Oxford Biomedica Plc
    • 16.2.9. Fujifilm Cellular Dynamics, Inc.
    • 16.2.10. Wuxi Apptec
    • 16.2.11. Charles River Laboratories International, Inc.
    • 16.2.12. The Discovery Labs LLC
    • 16.2.13. ABL, Inc.
    • 16.2.14. BioCentriq
    • 16.2.15. Commercializing Living Therapies

17. Strategic Recommendations

18. About Us & Disclaimer